載入...
Sulfasalazine-Induced Interstitial Fibrosis
Sulfasalazine has been used in the treatment of inflammatory bowel disease for over 60 years. Although the drug is frequently associated with gastrointestinal adverse effects, pulmonary adverse effects are very rare. Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalaz...
Na minha lista:
| 發表在: | Eurasian J Med |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Eurasian Journal of Medicine
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6263240/ https://ncbi.nlm.nih.gov/pubmed/30515045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurasianjmed.2018.17302 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|